Trial intelligence / Profile preview

Elidel vs Placebo in Atopic Dermatitis

NCT00180141Phase 4Completed

Sponsor
Technische Universität Dresden
Start
Apr 2005
Primary completion
Mar 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of pimecrolimus in atopic dermatitis (AD), sponsored by Technische Universität Dresden. Started Apr 2005; status: completed.

02

Drugs

pimecrolimus
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT00180141.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00180141.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call